The HIF-1α/PLOD2 axis integrates extracellular matrix organization and cell metabolism leading to aberrant musculoskeletal repair
Top Cited Papers
Open Access
- 12 March 2024
- journal article
- research article
- Published by Springer Nature in Bone Research
- Vol. 12 (1) , 1-13
Abstract
While hypoxic signaling has been shown to play a role in many cellular processes, its role in metabolism-linked extracellular matrix (ECM) organization and downstream processes of cell fate after musculoskeletal injury remains to be determined. Heterotopic ossification (HO) is a debilitating condition where abnormal bone formation occurs within extra-skeletal tissues. Hypoxia and hypoxia-inducible factor 1α (HIF-1α) activation have been shown to promote HO. However, the underlying molecular mechanisms by which the HIF-1α pathway in mesenchymal progenitor cells (MPCs) contributes to pathologic bone formation remain to be elucidated. Here, we used a proven mouse injury-induced HO model to investigate the role of HIF-1α on aberrant cell fate. Using single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics analyses of the HO site, we found that collagen ECM organization is the most highly up-regulated biological process in MPCs. Zeugopod mesenchymal cell-specific deletion of Hif1α (Hoxa11-CreERT2; Hif1afl/fl) significantly mitigated HO in vivo. ScRNA-seq analysis of these Hoxa11-CreERT2; Hif1afl/fl mice identified the PLOD2/LOX pathway for collagen cross-linking as downstream of the HIF-1α regulation of HO. Importantly, our scRNA-seq data and mechanistic studies further uncovered that glucose metabolism in MPCs is most highly impacted by HIF-1α deletion. From a translational aspect, a pan-LOX inhibitor significantly decreased HO. A newly screened compound revealed that the inhibition of PLOD2 activity in MPCs significantly decreased osteogenic differentiation and glycolytic metabolism. This suggests that the HIF-1α/PLOD2/LOX axis linked to metabolism regulates HO-forming MPC fate. These results suggest that the HIF-1α/PLOD2/LOX pathway represents a promising strategy to mitigate HO formation.Keywords
Funding Information
- U.S. Department of Health & Human Services | National Institutes of Health (R01AR071379, R01AR078324)
- U.S. Department of Health & Human Services | National Institutes of Health
This publication has 73 references indexed in Scilit:
- Hypoxia inducible factor (HIF) in the tumor microenvironment: friend or foe?Science China Life Sciences, 2017
- Cellular Hypoxia Promotes Heterotopic Ossification by Amplifying BMP SignalingJournal of Bone and Mineral Research, 2016
- The hypoxic tumor microenvironment: A driving force for breast cancer progressionBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2016
- The impact of hypoxia on mesenchymal progenitor cells of human skeletal tissue in the pathogenesis of heterotopic ossificationInternational Orthopaedics, 2015
- Early detection of burn induced heterotopic ossification using transcutaneous Raman spectroscopyBone, 2013
- Differential effects of homocysteine and beta aminopropionitrile on preosteoblastic MC3T3-E1 cellsBone, 2010
- Heterotopic ossification induced by Achilles tenotomy via endochondral bone formation: Expression of bone and cartilage related genesBone, 2010
- The role of matrix stiffness in regulating cell behavior†Hepatology, 2008
- Elevated formation of pyridinoline cross-links by profibrotic cytokines is associated with enhanced lysyl hydroxylase 2b levelsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2005
- [7] Collagen cross-linking amino acids1987